Literature DB >> 30703402

Toxic anterior segment syndrome: A review.

Erick Hernandez-Bogantes1, Alejandro Navas2, Andrea Naranjo3, Guillermo Amescua3, Enrique O Graue-Hernandez2, Harry W Flynn3, Ike Ahmed4.   

Abstract

Toxic anterior segment syndrome is a surgical complication characterized by a noninfectious anterior chamber inflammatory reaction having multiple etiologies. The clinical signs (prominent limbus-to-limbus corneal edema, anterior chamber inflammation) and symptoms (decreased visual acuity, discomfort) generally occur within the first 12-48 hours after intraocular surgery. Most patients achieve good clinical and visual outcomes when there is a prompt clinical diagnosis and adequate treatment. We review the literature on toxic anterior segment syndrome, emphasizing its etiology, pathophysiology, and clinical and surgical management, as well as prognosis and sequelae. Our goal is to reduce the frequency of toxic anterior segment syndrome by highlighting the importance of prevention, early recognition, and distinguishing toxic anterior segment syndrome from infectious endophthalmitis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anterior segment inflammation; anterior uveitis; cataract surgery; corneal edema; hypopyon; intracameral solutions; sterile inflammation; sterilization; topical steroids; toxic anterior segment syndrome

Mesh:

Year:  2019        PMID: 30703402     DOI: 10.1016/j.survophthal.2019.01.009

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

Review 1.  [Treatment of postoperative endophthalmitis : Operate or only inject?]

Authors:  L Mautone; C Skevas; M S Spitzer
Journal:  Ophthalmologe       Date:  2021-02-10       Impact factor: 1.059

2.  Timely vitrectomy without intraocular lens removal for acute endophthalmitis after cataract surgery.

Authors:  Hai-Xia Guo; Ruo-Tian Xie; Yun Wang; Cai-Yun You; Yuan-Yuan Liu; Xiang-Da Meng; Jin-Guo Yu; Hua Yan
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

3.  Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study.

Authors:  Prashanth G Iyer; Marc C Peden; Ivan J Suñer; Nish Patel; Sander R Dubovy; Thomas A Albini
Journal:  Am J Ophthalmol Case Rep       Date:  2020-11-10

4.  Toxic Intraocular Syndrome.

Authors:  Alfredo Amigó; Paula Martinez-Sorribes
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21

Review 5.  Postoperative Endophthalmitis and Toxic Anterior Segment Syndrome Prophylaxis: 2020 Update.

Authors:  Jesse D Sengillo; Ying Chen; Diley Perez Garcia; Stephen G Schwartz; Andrzej Grzybowski; Harry W Flynn
Journal:  Ann Transl Med       Date:  2020-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.